KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stereotaxis (STXS) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Stereotaxis (STXS) over the last 17 years, with Q3 2025 value amounting to -$6.6 million.

  • Stereotaxis' Income towards Parent Company fell 334.12% to -$6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.1 million, marking a year-over-year decrease of 746.79%. This contributed to the annual value of -$24.7 million for FY2024, which is 1327.9% down from last year.
  • Stereotaxis' Income towards Parent Company amounted to -$6.6 million in Q3 2025, which was down 334.12% from -$4.0 million recorded in Q2 2025.
  • Stereotaxis' Income towards Parent Company's 5-year high stood at -$1.5 million during Q1 2021, with a 5-year trough of -$7.6 million in Q4 2024.
  • In the last 5 years, Stereotaxis' Income towards Parent Company had a median value of -$5.2 million in 2022 and averaged -$5.0 million.
  • Its Income towards Parent Company has fluctuated over the past 5 years, first tumbled by 19557.8% in 2021, then surged by 3394.78% in 2025.
  • Quarter analysis of 5 years shows Stereotaxis' Income towards Parent Company stood at -$3.3 million in 2021, then plummeted by 33.05% to -$4.5 million in 2022, then dropped by 19.03% to -$5.3 million in 2023, then plummeted by 43.8% to -$7.6 million in 2024, then increased by 14.03% to -$6.6 million in 2025.
  • Its Income towards Parent Company stands at -$6.6 million for Q3 2025, versus -$4.0 million for Q2 2025 and -$5.9 million for Q1 2025.